Topic: COVID-19

Episode 60: Drug Shortages, Supply Chain, and Pharmacies During COVID-19

Niesha Griffith and Michael Ganio provide varying perspectives on the potential of drug shortages (eg, pain medications, cancer therapies, and hydroxychloroquine) emerging during the COVID-19 pandemic, as well as how the supply chain functions through the ASHP when a shortage is identified.

Episode 59: Economic Fallout of COVID-19 With Cam Harvey

Cam Harvey, PhD, professor of finance, Duke University, shares how his June 2019 prediction of a recession in 2020 is being further fueled by COVID-19, compares the pandemic to the likes of the Spanish Flu and SARS in terms of “systemic risk,” breaks down the finances of the recently enacted CARES Act, floats the idea of a federal strategic medical equipment reserve, and more.

BONUS: The Italian COVID-19 Experience With Stefano Luminari

Stefano Luminari, MD, associate professor of oncology, University of Modena (Italy), provides an update on the COVID-19 situation in Italy, including operational measures undertaken when there was an increase in demand for ICU hospital beds, the country’s underestimation of the seriousness of the disease at the beginning of the outbreak, how hospital staff are protecting themselves from the virus, and more.

Episode 57: The PPE Debacle During COVID-19 With Priya Sampathkumar

Priya Sampathkumar, MD, infectious disease specialist and hospital epidemiologist, Mayo Clinic, breaks down truths and misconceptions of which types of individuals should wear masks in public, proper gown and mask use for health care providers treating and not treating COVID-19, when N95 masks are truly needed and reasons for the potential shortage, and more in this provocative discussion.